Skip to main content
Clinical Trials/CTRI/2024/03/063770
CTRI/2024/03/063770
Completed
Phase 2

Spinal anaesthesia with levobupivacaine heavy and ropivacaine heavy forelective urological endoscopic surgeries- A prospective, double blinded,randomized study - Nil

Institute of Medical Sciences and SUM Hospital Hospital0 sites76 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptomsHealth Condition 2: O- Medical and Surgical
Sponsor
Institute of Medical Sciences and SUM Hospital Hospital
Enrollment
76
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 1, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Institute of Medical Sciences and SUM Hospital Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients undergoing elective urological surgeries
  • 2\. Patients within the age group of 18 to 60 years
  • 3\. Patients under ASA 1 and 2\.

Exclusion Criteria

  • 1\. Patient who are not willing to give consent for the study.
  • 2\. Patient known allergic to local anesthetic agents
  • 3\. Neurological, cardiovascular, respiratory, renal diseases
  • 4\. Platelet and coagulation disorders
  • 5\. Spine deformities or skin infection at local sites.

Outcomes

Primary Outcomes

Not specified

Similar Trials